Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Jarry

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Journal of Enzyme Inhibition and Medicinal Chemistry|March 13, 2010
Synthesis and evaluation of the antiproliferative activity of novel pyrrolo[1,2-a]quinoxaline derivatives, potential inhibitors of Akt kinase. Part IIVanessa Desplat, Stephane Moreau, Aurore Gay, et al.
Antimicrobial Agents and Chemotherapy|November 15, 2006
Synthesis of omeprazole analogues and evaluation of these as potential inhibitors of the multidrug efflux pump NorA of Staphylococcus aureusCéline Vidaillac, Jean Guillon, Corinne Arpin, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|June 16, 2010
Antiproliferative effect on HepaRG cell cultures of new calix[4]arenes. Part IILaurent Latxague, François Gaboriau, Olivier Chassande, et al.
European Journal of Medicinal Chemistry|June 7, 2014
Design of α7 nicotinic acetylcholine receptor ligands in quinuclidine, tropane and quinazoline series. Chemistry, molecular modeling, radiochemistry, in vitro and in rats evaluations of a [(18)F] quinuclidine derivativeFrédéric Pin, Johnny Vercouillie, Aziz Ouach, et al.
Bioorganic & Medicinal Chemistry|October 20, 2006
Synthesis, analytical behaviour and biological evaluation of new 4-substituted pyrrolo[1,2-a]quinoxalines as antileishmanial agentsJean Guillon, Isabelle Forfar, Maria Mamani-Matsuda, et al.
Journal of Medicinal Chemistry|April 2, 2004
Synthesis, antimalarial activity, and molecular modeling of new pyrrolo[1,2-a]quinoxalines, bispyrrolo[1,2-a]quinoxalines, bispyrido[3,2-e]pyrrolo[1,2-a]pyrazines, and bispyrrolo[1,2-a]thieno[3,2-e]pyrazinesJean Guillon, Philippe Grellier, Mehdi Labaied, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|January 22, 2011
Synthesis and evaluation of the antiproliferative activity of novel isoindolo[2,1-a]quinoxaline and indolo[1,2-a]quinoxaline derivativesVanessa Desplat, Stéphane Moreau, Solene Belisle-Fabre, et al.
Journal of Medicinal Chemistry|July 21, 2006
Probing the role of the covalent linkage of ferrocene into a chloroquine templateChristophe Biot, Wassim Daher, Cheikh M Ndiaye, et al.
European Journal of Medicinal Chemistry|April 5, 2011
New ferrocenic pyrrolo[1,2-a]quinoxaline derivatives: synthesis, and in vitro antimalarial activity--Part IIJean Guillon, Elisabeth Mouray, Stéphane Moreau, et al.
Clinical Oral Implants Research|October 18, 2018
Group 2 ITI Consensus Report: Prosthodontics and implant dentistryDean Morton, German Gallucci, Wei-Shao Lin, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Journal of Enzyme Inhibition and Medicinal Chemistry|March 13, 2010
Synthesis and evaluation of the antiproliferative activity of novel pyrrolo[1,2-a]quinoxaline derivatives, potential inhibitors of Akt kinase. Part IIVanessa Desplat, Stephane Moreau, Aurore Gay, et al.
Antimicrobial Agents and Chemotherapy|November 15, 2006
Synthesis of omeprazole analogues and evaluation of these as potential inhibitors of the multidrug efflux pump NorA of Staphylococcus aureusCéline Vidaillac, Jean Guillon, Corinne Arpin, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|June 16, 2010
Antiproliferative effect on HepaRG cell cultures of new calix[4]arenes. Part IILaurent Latxague, François Gaboriau, Olivier Chassande, et al.
European Journal of Medicinal Chemistry|June 7, 2014
Design of α7 nicotinic acetylcholine receptor ligands in quinuclidine, tropane and quinazoline series. Chemistry, molecular modeling, radiochemistry, in vitro and in rats evaluations of a [(18)F] quinuclidine derivativeFrédéric Pin, Johnny Vercouillie, Aziz Ouach, et al.
Bioorganic & Medicinal Chemistry|October 20, 2006
Synthesis, analytical behaviour and biological evaluation of new 4-substituted pyrrolo[1,2-a]quinoxalines as antileishmanial agentsJean Guillon, Isabelle Forfar, Maria Mamani-Matsuda, et al.
Journal of Medicinal Chemistry|April 2, 2004
Synthesis, antimalarial activity, and molecular modeling of new pyrrolo[1,2-a]quinoxalines, bispyrrolo[1,2-a]quinoxalines, bispyrido[3,2-e]pyrrolo[1,2-a]pyrazines, and bispyrrolo[1,2-a]thieno[3,2-e]pyrazinesJean Guillon, Philippe Grellier, Mehdi Labaied, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|January 22, 2011
Synthesis and evaluation of the antiproliferative activity of novel isoindolo[2,1-a]quinoxaline and indolo[1,2-a]quinoxaline derivativesVanessa Desplat, Stéphane Moreau, Solene Belisle-Fabre, et al.
Journal of Medicinal Chemistry|July 21, 2006
Probing the role of the covalent linkage of ferrocene into a chloroquine templateChristophe Biot, Wassim Daher, Cheikh M Ndiaye, et al.
European Journal of Medicinal Chemistry|April 5, 2011
New ferrocenic pyrrolo[1,2-a]quinoxaline derivatives: synthesis, and in vitro antimalarial activity--Part IIJean Guillon, Elisabeth Mouray, Stéphane Moreau, et al.
Clinical Oral Implants Research|October 18, 2018
Group 2 ITI Consensus Report: Prosthodontics and implant dentistryDean Morton, German Gallucci, Wei-Shao Lin, et al.
Pageof 4